Congratulations to the Horizon base editing R&D team for co-authoring one of the top 5 most downloaded CRISPR Journal articles in 2021, with Rutgers University!
This article describes Pin-pointTM a novel first-generation base editing system that Horizon is continuing to develop for cell and gene therapy applications.
Access the article today!
Want to learn more about the promise of base editing and the Pin-point platform?
Read on below to see what our R&D team has been working on recently.
Journal articles by Horizon scientists
- Immunotherapy to get on point with base editing
- Breaking away from DNA Breaks
- Next generation gene therapy points to base editing
- Could engineered cell therapies be broken by double-strand breaks?
- Therapeutic promise of base editing (sickle cell disease)
- Base editing goes big: A role in functional pooled screening
- The future of cell-based immunotherapy: autologous vs allogeneic treatment
- Therapeutics get on point with base editors
- CRISPR 2.0: base editing in the groove
- Base editing could improve cell and gene therapies and make them cheaper, says Horizon Discovery scientist
Webinars and Podcasts
- Advancing engineered cell and gene therapy with precision gene editing
- The therapeutic gene editing solution - cell therapy for solid tumors
- CRISPR Functional Genomics Miniseries, Episode #13: Jennifer Harbottle on Base Editing
- CRISPR Functional Genomics Miniseries, Episode #14: Kevin Hemphill on the Future of Base Editing
Learn about Horizon's Pin-point base editing platform